Streetbeat News

Price Targets

VRTX

Vertex Pharmaceuticals (NASDAQ:VRTX) has received a mix of bullish and indifferent analyst ratings over the last quarter, with no bearish ratings. Out of 16 analysts, 3 are bullish, 7 are somewhat bullish, and 6 are indifferent. The average price target is $382.31, representing an upside from the current price of $353.59. This target has increased by 3.86% over the past month. Analysts provide ratings based on research and forecasts, and these ratings are updated typically once a quarter.

Portfolio Pulse from Benzinga Insights

December 11, 2023 | 2:00 pm

KHC

Kraft Heinz (NASDAQ:KHC) has received mixed analyst ratings over the last quarter, with 1 bullish, 2 somewhat bullish, and 6 indifferent. The average 12-month price target among 9 analysts is $37.33, with a high of $42.00 and a low of $34.00. This target is a 6.68% decrease from the previous target of $40.00. Analyst ratings are based on financial analysis and are subject to human error.

Portfolio Pulse from Benzinga Insights

December 11, 2023 | 2:00 pm

UDR

UDR (NYSE:UDR) has received 8 analyst ratings in the last quarter with 0 bullish, 2 somewhat bullish, 5 indifferent, 1 somewhat bearish, and 0 bearish. The average price target is $36.62, representing an upside from the current price of $35.37. This is a 14.12% decrease from the previous average price target of $42.64.

Portfolio Pulse from Benzinga Insights

December 11, 2023 | 2:00 pm

ILMN

Analysts have provided mixed ratings for Illumina (NASDAQ:ILMN) in the last quarter, with an equal number of bullish and bearish sentiments. The average 12-month price target for ILMN is $155.12, which is an 18.71% decrease from the previous target of $190.83. Ratings are distributed across bullish, somewhat bullish, indifferent, and somewhat bearish, with no fully bearish ratings.

Portfolio Pulse from Benzinga Insights

December 11, 2023 | 2:00 pm

CPT

Camden Prop Trust (NYSE:CPT) received 9 analyst ratings in the last quarter with an average 12-month price target of $105.44, a decrease of 10.5% from the previous target of $117.81. Ratings include 4 bullish, 3 somewhat bullish, and 2 somewhat bearish. The high price target is $138.00 and the low is $80.00.

Portfolio Pulse from Benzinga Insights

December 11, 2023 | 2:00 pm

NAPA

BMO Capital analyst Andrew Strelzik has maintained a Market Perform rating on Duckhorn Portfolio (NYSE:NAPA) but has lowered the price target from $13 to $11.

Portfolio Pulse from Benzinga Newsdesk

December 11, 2023 | 1:59 pm

LII

Stephens & Co. analyst Rob McCarthy has upgraded Lennox Intl (NYSE:LII) from Equal-Weight to Overweight and set a price target of $550.

Portfolio Pulse from Benzinga Newsdesk

December 11, 2023 | 1:59 pm

IRTC

Citigroup analyst Joanne Wuensch has upgraded iRhythm Technologies (NASDAQ:IRTC) from Neutral to Buy and set a price target of $110.

Portfolio Pulse from Benzinga Newsdesk

December 11, 2023 | 1:56 pm

SNAP

Snap Inc. shares have risen following an upgrade by Wells Fargo from Equal-Weight to Overweight, with a significant increase in the price target from $8 to $22.

Portfolio Pulse from Benzinga Newsdesk

December 11, 2023 | 1:55 pm

PVH

Wells Fargo analyst Ike Boruchow has maintained an Overweight rating on PVH Corp (NYSE:PVH) and increased the price target from $110 to $140, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

December 11, 2023 | 1:50 pm